Sun Pharma Earnings
- All
- News
- Videos
-
Sun Pharma Shares Tank Over 4% After Q4 Earnings
Shares of Sun Pharmaceutical Industries fell by over 4 per cent in morning trade on Tuesday a day after the company said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss.
-
Sun Pharma Records Rs 2,277 Crore March Quarter Net Loss
Sun Pharmaceutical Industries on Monday said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022
-
Sun Pharma Profit Rises 13% In September Quarter; Shares Gain Over 2.5%
Sun Pharma's India sales jumped 26 per cent to Rs 3,187 crore while its sales in the US came in at $361 million, up 8 per cent annually.
-
Sensex, Nifty Edge Higher; Axis Bank Falls After September Quarter Earnings
Asian Paints, Reliance Industries, Infosys, HDFC, TCS and Sun Pharma were among the top movers in the Sensex.
-
Sun Pharma Returns To Profit In Q1, Stock Climbs 10% To New 52-Week High
Sun Pharma's earnings before interest, tax, depreciation and amortisation or operating profit advanced 59 per cent annually to Rs 2,771.8 crore
-
Sensex, Nifty End Flat; Sun Pharma Surges Over 10% On Strong Q1 Earnings
Gains in Sun Pharma, Tech Mahindra and HDFC were offset with losses in Reliance Industries, Bajaj Finance and State Bank of India.
-
Sun Pharma Q2 Profit At Rs 1,064 Crore, Shares Jump Over 3%
On the BSE, the Sun Pharma stock jumped as much as 3.15 per cent to Rs 441.00 apiece after the earnings announcement.
-
Sun Pharma Profit Up 31% At Rs 1,387 Crore In June Quarter, Shares Jump Over 5%
Shares in Sun Pharma jumped as much as 5.43 per cent after the earnings announcement.
-
New Government Formation, GDP Data, Derivatives Expiry To Guide Markets: Experts
In terms of quarterly results, companies like Abbott India, Bharat Heavy Electricals, Emami, GAIL, Interglobe Aviation, Punjab National Bank, SpiceJet, Sun Pharma, GMR Infra, M&M and Power Finance Corp are expected to announce their fourth quarter (Q4) earnings results in the coming week.
-
Sun Pharma Shares Jump After Company's Quarterly Profit Rises Nearly 4 Times
Sun Pharma shares price today jumped more than 4 per cent in intraday trade. Sun Pharma the previous day reported a nearly four-fold increase in quarterly net profit. Sun Pharma said it had incurred a one-time tax expense of Rs 513 crore - related to changes in US tax rates - in the year-ago period.
-
Sun Pharma Reports Nearly Four-Fold Jump In December Quarter Profit
Sun Pharmaceutical Industries' total revenue from operations grew 16.3 per cent to Rs 7740 crore.
-
Sun Pharma Reports Surprise Loss Of 219 Crore Rupees In September Quarter
Sun Pharma said its total revenue from operations rose 4.3 per cent to Rs 6,938 crore in the quarter.
-
Markets Break 2-Day Fall: Sensex Rises 207 Points, Nifty Reclaims 11,400
Stock market on Tuesday: Pharma stocks also surged, with the Nifty Pharma closing 3.2 per cent higher. Pharma gains were led by heavyweight Sun Pharma, after the drug maker reported its earnings for the April-June period.
-
Sun Pharma's Q2 Profit Plunges 59%, Beats Estimates
Profit came in at Rs 912 crore in the quarter ended September 30, compared with Rs 2,235 crore a year ago, the company said.
-
Sun Pharma Reports Rs 425 Crore Loss In Q1 As Generics Business Suffers
Mumbai-based Sun Pharma posted a net loss of Rs 425 crore for the April-June quarter compared with a profit of Rs 2,034 crore a year earlier.
-
Sun Pharma Shares Tank Over 4% After Q4 Earnings
Shares of Sun Pharmaceutical Industries fell by over 4 per cent in morning trade on Tuesday a day after the company said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss.
-
Sun Pharma Records Rs 2,277 Crore March Quarter Net Loss
Sun Pharmaceutical Industries on Monday said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022
-
Sun Pharma Profit Rises 13% In September Quarter; Shares Gain Over 2.5%
Sun Pharma's India sales jumped 26 per cent to Rs 3,187 crore while its sales in the US came in at $361 million, up 8 per cent annually.
-
Sensex, Nifty Edge Higher; Axis Bank Falls After September Quarter Earnings
Asian Paints, Reliance Industries, Infosys, HDFC, TCS and Sun Pharma were among the top movers in the Sensex.
-
Sun Pharma Returns To Profit In Q1, Stock Climbs 10% To New 52-Week High
Sun Pharma's earnings before interest, tax, depreciation and amortisation or operating profit advanced 59 per cent annually to Rs 2,771.8 crore
-
Sensex, Nifty End Flat; Sun Pharma Surges Over 10% On Strong Q1 Earnings
Gains in Sun Pharma, Tech Mahindra and HDFC were offset with losses in Reliance Industries, Bajaj Finance and State Bank of India.
-
Sun Pharma Q2 Profit At Rs 1,064 Crore, Shares Jump Over 3%
On the BSE, the Sun Pharma stock jumped as much as 3.15 per cent to Rs 441.00 apiece after the earnings announcement.
-
Sun Pharma Profit Up 31% At Rs 1,387 Crore In June Quarter, Shares Jump Over 5%
Shares in Sun Pharma jumped as much as 5.43 per cent after the earnings announcement.
-
New Government Formation, GDP Data, Derivatives Expiry To Guide Markets: Experts
In terms of quarterly results, companies like Abbott India, Bharat Heavy Electricals, Emami, GAIL, Interglobe Aviation, Punjab National Bank, SpiceJet, Sun Pharma, GMR Infra, M&M and Power Finance Corp are expected to announce their fourth quarter (Q4) earnings results in the coming week.
-
Sun Pharma Shares Jump After Company's Quarterly Profit Rises Nearly 4 Times
Sun Pharma shares price today jumped more than 4 per cent in intraday trade. Sun Pharma the previous day reported a nearly four-fold increase in quarterly net profit. Sun Pharma said it had incurred a one-time tax expense of Rs 513 crore - related to changes in US tax rates - in the year-ago period.
-
Sun Pharma Reports Nearly Four-Fold Jump In December Quarter Profit
Sun Pharmaceutical Industries' total revenue from operations grew 16.3 per cent to Rs 7740 crore.
-
Sun Pharma Reports Surprise Loss Of 219 Crore Rupees In September Quarter
Sun Pharma said its total revenue from operations rose 4.3 per cent to Rs 6,938 crore in the quarter.
-
Markets Break 2-Day Fall: Sensex Rises 207 Points, Nifty Reclaims 11,400
Stock market on Tuesday: Pharma stocks also surged, with the Nifty Pharma closing 3.2 per cent higher. Pharma gains were led by heavyweight Sun Pharma, after the drug maker reported its earnings for the April-June period.
-
Sun Pharma's Q2 Profit Plunges 59%, Beats Estimates
Profit came in at Rs 912 crore in the quarter ended September 30, compared with Rs 2,235 crore a year ago, the company said.
-
Sun Pharma Reports Rs 425 Crore Loss In Q1 As Generics Business Suffers
Mumbai-based Sun Pharma posted a net loss of Rs 425 crore for the April-June quarter compared with a profit of Rs 2,034 crore a year earlier.
